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Summary
Objectives: Osteoarthritis (OA) is characterized by the failure of chondrocytes to respond to injury and perform the cartilage remodeling pro-
cess. Human articular chondrocytes actively produce reactive oxygen and nitrogen species (ROS and RNS) capable of causing cellular dys-
function and death. A growing body of evidence indicates that mitochondrial dysfunction and mitochondrial DNA (mtDNA) damage play
a causal role in disorders linked to excessive generation of oxygen free radicals. The aim of this study was to determine whether mtDNA dam-
age was present in OA chondrocytes, and whether mtDNA repair capacity is compromised in OA chondrocytes following oxidative stress,
leading to chondrocyte death.
Methods: Human articular cartilage was isolated from knee joints of cadavers available through the Anatomical Gifts Program at the University
of South Alabama (normal donors) or OA patients undergoing total knee replacement surgeries (OA patients). Total DNA was isolated from
either chondrocytes released following collagenase digestion, or from ﬁrst passage chondrocytes grown in culture and exposed to ROS or
RNS. mtDNA integrity and repair capacity were analyzed by quantitative Southern blot analysis, using a mtDNA-speciﬁc radioactive probe.
Cell viability was determined by the trypan blue exclusion method.
Results: mtDNA damage was found in chondrocytes from OA patients compared to normal donors. It was accompanied with reduced mtDNA
repair capacity, cell viability, and increased apoptosis in OA chondrocytes following exposure to ROS and RNS.
Conclusions: These results indicate that mtDNA damage and poor mtDNA repair capacity for removing damage caused by oxidative stress
may contribute to the pathogenesis of OA.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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A growing body of evidence suggests that reactive oxygen
species (ROS) play a critical role in the regulation of normal
chondrocyte function and contribute to the structural and
functional cartilage damage observed in the pathogenesis
of joint disease. ROS regulate some normal chondrocyte
activities such as cell activation, proliferation and matrix
remodeling1e3. In response to partial oxygen pressure
variations, mechanical stress, and immunomodulatory and
inﬂammatory mediators, chondrocytes produce abnormal
levels of ROS. When ROS production exceeds the antiox-
idant and repair capacities of the cell, oxidative stress
occurs which leads to cartilage damage. Free radical elicited
oxidative stress can lead to DNA, protein, and other cel-
lular macromolecule damages, which ultimately can result
in cellular dysfunction and death.
Numerous reports have demonstrated that oxidative
damage, due to the overproduction of nitric oxide (NO) and
other ROS, may be involved in the pathogenesis of oste-
oarthritis (OA)4e6. Lower antioxidative capacity and stron-
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107and NO, were observed in degenerating regions of OA
cartilage, as compared with the intact regions from the
same explants7. Immunostaining for nitrotyrosine corre-
lated with the severity of histological changes to OA
cartilage, suggesting an association between oxidative
damage and articular cartilage degeneration. Other stud-
ies have demonstrated that oxidative stress affects chon-
drocyte telomeric DNA, replicative lifespan, and cartilage
matrix proteoglycan structure and composition8e10. Addi-
tionally, OA patients exhibit a signiﬁcant increase in DNA
damage in peripheral blood leukocytes and erythrocyte
lipid peroxydation, along with decreased antioxidant levels,
including plasma glutathione, ascorbic acid, vitamin E and
catalase11,12.
Oxidative stress-induced cellular alterations are observed
during age-related degeneration of mitochondria resulting
from leakage from the electron transport chains and signif-
icant oxidative damage to mitochondrial macromolecules13.
Despite the fact that disrupted mitochondrial respiration and
mitochondrial damage have been found to expedite aging,
and cause cellular dysfunction, degeneration, and death,
the contribution of mitochondrial dysfunction to the patho-
genesis of OA has not been fully elucidated. However, it
has been shown that oxygen does diffuse into articular
cartilage, and articular chondrocytes possess functional
mitochondria. Mitochondrial oxidative phosphorylation
(OXPHOS) may account for up to 25% of the adenosine tri-
phosphate (ATP) produced in cartilage14. Respiratory chain
108 V. I. Grishko et al.: Mitochondrial DNA in OA chondrocytesactivity and mitochondrial membrane potential have been
found to be signiﬁcantly reduced in cultured human chon-
drocytes from OA patients, when compared to normal
donors15. A key factor likely playing a role in oxidative
stress-induced mitochondrial dysfunction is mitochondrial
DNA (mtDNA). Each mitochondrion has multiple copies of
its own genome. It is widely regarded that the mitochondrial
genome is prone to oxidative damage, being between 10-
and 100-fold more sensitive to this stress than nuclear
DNA16. Moreover, mutations and deletions in the mitochon-
drial genome have been linked to neurodegenerative disor-
ders and other age-related diseases17,18. Depletion of
mtDNA is known to suppress ATP synthesis and cause
defects in cellular function19. Additionally, there is evidence
which suggests the involvement of mtDNA damage in the ini-
tiation of apoptosis20. It remains unclear whether this is appli-
cable to the chondrocyte, which has low oxygen
consumption and, therefore, might be less prone to oxidative
damage to its mtDNA. Therefore, the purpose of the current
investigation was to evaluate whether mtDNA damage and
mtDNA repair dysfunction are present during the develop-
ment of OA.Experimental proceduresCARTILAGE SPECIMENS AND ESTABLISHMENT OF PRIMARY
CULTURES OF CHONDROCYTESTwo types of cartilage were used for the current investi-
gation: cartilage obtained as surgical waste from total
knee replacement surgery of 24 OA patients and cartilage
from 13 age-matched normal donors obtained through the
University of South Alabama Anatomical Gifts Program.
Cartilage from OA patients was obtained from areas within
the distal femur without exposed bone. Cartilage obtained
from normal donors was used only if there was no gross
evidence of cartilage abnormalities within the knee. No
radiographs of normal donor knees were obtained prior to
testing. OA patients ranged in age from 54 to 69 years,
and normal donor ages ranged from 62 to 74 years. Primary
chondrocyte cultures from normal donors and OA patients
were generated by overnight digestion of minced cartilage
samples with 5-mg/ml collagenase B (Roche) in DMEM/
F12 media (Dulbecco’s Modiﬁcation of Eagle’s Medium/
Ham F-12 50/50 Mix) (Cellgro) supplemented with 10% fetal
bovine serum (FBS; Hyclone). Cells were allowed to attach
for 48 h before the ﬁrst media change. Following this time,
90e95% of the cells were attached and these adherent
cells were used for experiments. Part of the resulting chon-
drocyte yield was lysed for DNA isolation in order to perform
comparative mtDNA damage studies between OA patients
and normal donors. The remaining cells were plated in
100 mm dishes in culture medium containing DMEM/F12
with 50 ng/ml of gentamycin (Gibco BRL) and 10% FBS
and used, after reaching conﬂuence (7e10 days), for repair
and viability experiments. Only ﬁrst passage cells were
used for experiments in order to preserve chondrocyte
phenotype.DRUG PREPARATION AND EXPOSUREFor dose response and repair experiments with ROS or
reactive nitrogen species (RNS) generators, primary chon-
drocyte cultures were exposed to 150, 300, and 600 mM
of peroxynitrite (Cayman Chemicals) or 10, 20, and
40 mU of xanthine oxidase (XO)/with 0.5-mM hypoxanthine
(Sigma) in serum-free DMEM/F12 medium. Control cultureswere exposed to serum-free DMEM/F12 media only. Chon-
drocytes were exposed to these genotoxins for a duration of
30 min, after which cells were lysed immediately, or rinsed
and placed in culture medium to allow time for recovery
and repair.mtDNA DAMAGE AND REPAIR ASSAYChondrocyte cultures or cell suspensions were lysed in
a buffer containing 0.5% sodium dodecyl sulfate (SDS),
10-mM TriseHCl (pH 8.0), 20-mM ethylenediamine tetraa-
cetate acid (EDTA) (pH 8.0), 100-mM NaCl, and 300-mg/
ml proteinase K (Roche) overnight in a 37C water bath.
For repair experiments, cultures were lysed immediately fol-
lowing drug exposure, or replenished with culture media
and left for repair for 6 h. Once the cells were lysed, DNA
was isolated by a standard phenol/chloroform extraction
method, precipitated with cold ethanol, and subjected to
overnight digestion with BamHI (10-U/mg DNA). BamHI
was selected because human mtDNA has a single restric-
tion site for this enzyme, so that upon digestion it linearizes
the mtDNA. Hybridization with the human mitochondrial
gene-speciﬁc probe to cytochrome c oxidase subunit III rec-
ognizes the restriction band of 16,569 bp, corresponding to
the whole mitochondrial genome. Each DNA sample was
precisely quantiﬁed with a Hoefer TKO100 mini-ﬂuorometer
using Hoechst 33258 dye. Prior to loading on an alkaline
agarose gel for Southern blot analysis, each sample con-
taining 5 mg of total DNA was incubated with 0.1-N NaOH
to reveal single-strand breaks. After the gel electrophoresis
was completed, DNA was stained with ethidium bromide
and viewed under ultraviolet (UV) light to ensure loading ac-
curacy. Next, DNA was transferred via vacuum to a nylon
membrane and hybridized with a polymerase chain reaction
(PCR)-generated radioactive mtDNA-speciﬁc probe, which
contained the sequence for part of the cytochrome c oxi-
dase subunit III human mitochondrial gene. Autoradiograms
were scanned for hybridization band intensity. mtDNA dam-
age was assessed as the diminished intensity in the 10 kb
major restriction band, indicating that DNA breaks have
caused smaller size fragments, which migrate further
down in the gel and, thus, reduced the number of full size
restriction fragments. For DNA repair studies, the break fre-
quency was determined using the Poisson expression
(s¼ln P0, where s is the number of breaks per fragment,
and P0 is the fraction of fragments that are free of breaks).
The extent of repair was calculated as the value obtained
from subtracting the breaks at time t from the breaks pres-
ent at t¼ 0 h, and dividing by the breaks at t¼ 0 h. The re-
sulting value was then converted to a percentage by
multiplying by 10021.SLOT-BLOT ANALYSISThis assay was used to determine whether there were
any differences in mtDNA content between different DNA
samples. DNA samples obtained from normal donors and
OA patients were digested with BamHI, precisely quanti-
ﬁed, adjusted to the same concentration with H2O, and
treated with 0.3-M NaOH to denature the DNA. Fractions
of 100, 50, and 20 ng were then blotted onto a nylon mem-
brane (Nytran, Schleicher and Schuell, Keen, NH) using
a slot blot apparatus (Minifold II, Schleicher and Schuell)
and membranes were hybridized with a mtDNA-speciﬁc
probe and washed according to the manufacturer’s
suggestions.
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and exposed to the same concentrations of peroxynitrite
and XO used for the repair experiments. Following 30 min
of exposure, the cells were replenished with normal growth
media and allowed to recover for 24 h. After 24 h, trypan
blue (Sigma) was added to the trypsinized cells to distinguish
dead cells from live ones. Viable cells were counted in a
hemocytometer using a light microscope and expressed
as a percentage of the total number of cells. Apoptotic
cells were identiﬁed using the DAPI (40,6-diamidino-2-phe-
nylindole; Sigma) staining method. Brieﬂy, 24 h following
exposure to the ROS/RNS generators, cells were washed
three times with phosphate-buffered saline (PBS) and
ﬁxed with 4% paraformaldehyde. The ﬁxed cells were
washed again with PBS and stained with 1-mg/ml DAPI,
a ﬂuorescent dye that binds to DNA. Stained cells were
examined by ﬂuorescent microscopy to identify apoptotic
cells, which were deﬁned morphologically by cytoplas-
mic and nuclear shrinkage, chromatin condensation or
fragmentation. To evaluate the percentage of apoptotic
cells, 6e7 ﬁelds from each experimental condition were
viewed in a blinded fashion until a total of 500 cells were
observed.STATISTICAL ANALYSISFig. 1. mtDNA is damaged during the pathogenesis of OA. (A) isStatistical analyses were performed using either Student’s
t test, or one- or two-way analysis of variance (GraphPad
Prism) where appropriate. A difference of P< 0.05 was con-
sidered signiﬁcant. The Bonferroni post hoc test was used to
determine the source of difference.a representative autoradiogram from Southern blot analyses
of mtDNA from three normal donors (lanes 1e3) and three OA
patients (line 4e6). Human chondrocytes were lysed for DNA
extraction following overnight digestion with collagenase B. The
reduced intensity of the hybridization bands indicates that mtDNA
damage has increased. (B) displays a comparison of the hybridiza-
tion band intensities obtained from the Southern blot analysis of 13
normal donors and 24 OA patients. * indicates a signiﬁcant differ-
ence (P< 0.05) between normal donors and OA patients. (C) is
a representative autoradiogram from slot-blot analyses performed
on the DNA from normal donors and OA patients and shows that
there is no variation in the amount of mtDNA between normal do-
nors and OA patients, as well as between separate DNA samples.Results
There are two components to the present study. The ﬁrst
is the investigation of the mtDNA damage which has accu-
mulated in cartilage from OA patients compared to normal
donors. The second is the study of mtDNA repair capacity
and cell viability following experimentally induced oxidative
stress in chondrocytes from OA patients and normal donors.
To compare mtDNA integrity between normal donors and
OA patients, DNA was isolated directly from chondrocyte
suspensions after collagenase digestion of cartilage spec-
imens, and Southern blot analysis was performed to reveal
the extent of mtDNA damage [Fig. 1(A)]. First, we wanted
to make sure that differences in mtDNA integrity in normal
donors compared to OA patients were not due to damage
to mtDNA in OA chondrocytes caused by the collagenase
digestion. Immediately following overnight digestion with
collagenase, the resulting cells were evaluated for viability
using trypan blue exclusion. In the normal chondrocyte
cultures 87 5% of the cells viable, while in OA chondro-
cyte cultures, viability was 82 9%. These results show
that the vast majority of cells in either group had intact
plasma membranes. Thus, it is unlikely that any mtDNA
damage seen in OA chondrocytes is the result of collage-
nase entering mitochondria and damaging their DNA.
The results of this study indicated that mtDNA integrity
was better maintained in normal donors compared to OA
patients, as demonstrated by the greater intensity of the
major restriction bands from normal donors compared to
the lower intensity of bands obtained from OA patients
[Fig. 1(B)]. In other words, this ﬁnding indicated that mtDNA
from OA patients sustained more damage than that from
healthy controls. To ensure that differences betweenhybridization band intensities were due to mtDNA damage
and not mtDNA content, slot-blot analysis of all samples
used for Southern blot analysis was performed. This analy-
sis revealed that there were no differences in the amount of
mtDNA between DNA samples from normal donors and OA
patients [Fig. 1(C)]. The same gels were used to evaluate
possible nuclear DNA damage. To perform this study, quan-
titative alkaline gel electrophoresis analysis was used.
Following alkaline electrophoresis, gels were stained with
ethidium bromide and total cellular DNA integrity was
assessed using densitometric software (BioRad GS-250
molecular imager). This analysis revealed that any nuclear
DNA damage present in the samples from either normal
donors or OA patients was below the level of detection
(data not shown).
To evaluate the ability of chondrocytes to repair damage
to mtDNA caused by ROS or RNS, chondrocytes in primary
culture, from either OA patients or normal donors, were ex-
posed to the ROS generator XO/hypoxanthine or the RNS
generator peroxynitrirte. Initial doseeresponse experiments
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required to induce approximately 1 break per 10 kb ofmtDNA.
Cells were treated with different doses of XO/hypoxanthine
or peroxynitrite for 30 min and lysed overnight. Total DNA
was isolated, digested with BamHI, and subjected to
quantitative Southern blot analysis. As can be seen in
Fig. 2, chondrocytes treated with 300 mM of peroxynitrite
or 20 mU of XO/0.5-mM hypoxanthine showed the de-
sired levels of mtDNA damage, and these concentrations
were used for repair experiments. Chondrocytes obtained
from OA patients were more sensitive to both peroxyni-
trite and XO than normal donors (Fig. 2). These results
indicate that mtDNA from normal donors and OA patients
are vulnerable targets for stress caused by either ROS
or RNS and that mtDNA from OA chondrocytes is more
sensitve to either stress.
For repair experiments, following exposure to ROS or
RNS, cultures were either lysed immediately, and DNA ex-
tracted for initial DNA damage evaluation, or replenished
with normal culture medium and allowed to repair for 6
and 24 h before cells were lysed and DNA isolated.150 µM 300 µM 600 µM
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Fig. 2. mtDNA in chondrocytes from OA patients is more sensitive
to oxidative stress caused by exposure to ROS or RNS. Chondro-
cytes were exposed to increased concentrations of peroxynitrite
(panel A) or XO with hypoxanthine (panel B) for 30 min. Cells
were lysed, DNA was isolated and subjected to Southern blot anal-
ysis. An increase in the break frequency indicates that more mtDNA
damage has accumulated. The results were obtained from a mini-
mum of eight independent experiments, and the values represent
the mean break frequency S.E.M. * indicates a signiﬁcant differ-
ence (P< 0.05) in damage in mtDNA in chondrocytes from OA
patients compared to normal donors.Southern blot analysis was performed on the extracted
DNA to determine the differences in the integrity of mtDNA
immediately after the damage was introduced or following
the two intervals for repair. Autoradiograms were scanned,
break frequencies calculated based on densitometry mea-
surements, and a percentage of repair was calculated. By
6 h after exposure to either the ROS or RNS, mtDNA had
been repaired somewhat, as indicated by the decrease in
the break frequency at 6 h following drug treatment compared
to the break frequencies at 0 h (Fig. 3). After 24 h, there was
not a signiﬁcant increase in repair following exposure to either
free radical. These data show that human chondrocytes have
a limited capacity to repair oxidative damage. Additionally, OA
chondrocytes had decreased mtDNA repair compared to
chondrocytes from normal donors. These data indicate that
the capacity to repair mtDNA is compromised during the pro-
gression of OA and potentially contributes to the progressive
mitochondrial dysfunction.
A similar experimental design to that used for the repair
studies was utilized to evaluate viability and apoptosis of
normal and OA chondrocytes following oxidative stress6 h 24 h
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Fig. 3. OA chondrocytes have a diminished capacity to repair oxida-
tive damage. Primary human chondrocytes from OA patients and
normal donors were exposed to 300 mM of peroxynitrite (panel A)
or 20-mU XO/0.5-mM hypoxanthine for 30 min and allowed to
repair for 6 and 24 h. Cells were lysed, DNA was isolated and sub-
jected to Southern blot analysis. The results were obtained from
a minimum of seven independent experiments, and the values dis-
played represent the mean break frequency S.E.M. * indicates
a signiﬁcant difference (P< 0.05) between OA chondrocytes and
those isolated from normal donors.
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Fig. 5. The accumulation of apoptotic chondrocytes in cultures ob-
tained from OA patients and normal donors following exposure to
ROS or RNS. Twenty-four hours following exposure to increasing
concentrations of XO or peroxynitrite, cells were washed three
times with PBS and ﬁxed with 4% paraformaldehyde. The ﬁxed
cells were washed again with PBS and stained with 1-mg/ml
DAPI. Stained cells were examined by ﬂuorescent microscopy to
identify apoptotic cells. To evaluate the percentage of apoptotic
cells, 6e7 ﬁelds from each experimental condition were viewed in
a blinded fashion until a total of 500 cells were observed. The re-
sults were obtained from a minimum of six independent experi-
ments, and the values represent the mean percentage of
apoptotic cells  S.E.M. * indicates a signiﬁcant difference
(P< 0.05) in the percentage of apoptotic cells in cultures from
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were seeded in 24-well plates and after reaching conﬂu-
ence were treated for 30 min with 300 mM of peroxynitrite
or 20-mU XO/0.5-mM hypoxanthine. Following 24 h of
recovery, cells were trypsinized, incubated with trypan blue
dye, and the percentages of viable (white) and dead
(blue) cells were calculated. The results of these studies
indicated that, after oxidative stress was introduced, more
chondrocytes from normal donors were viable than chon-
drocytes from OA patients (Fig. 4). Signiﬁcant differences
were observed between normal and OA chondrocytes after
treatment with 300- and 600-mM peroxynitrite and all con-
centrations of XO with hypoxanthine following 24 h of recov-
ery. These results show that OA chondrocyte function is
already diminished by oxidative stress, which has accumu-
lated during the progression of OA and this makes it difﬁcult
for these cells to recover and preserve their viability when
additional oxidative stress is introduced.
Studies were performed to evaluate the induction of apo-
ptosis in both normal and OA chondrocytes following expo-
sure to ROS or RNS. Primary cell cultures were exposed to
the same doses of peroxynitrite or XO as were used for the
repair and viability studies. Following 24 h of recovery, cells
were ﬁxed and stained with DAPI. Stained cells were exam-
ined by ﬂuorescent microscopy to identify apoptotic cells,
which were deﬁned morphologically by cytoplasmic and
nuclear shrinkage, and chromatin condensation or fragmen-
tation. To evaluate the percentage of apoptotic cells, 6e7
ﬁelds from each experimental condition were viewed, in
a blinded fashion, until a total of 500 cells were observed.
Data obtained from these studies show that primary cul-
tures of human chondrocytes, obtained from OA patients,
contained signiﬁcantly greater amounts of apoptotic cells
following oxidative stress (Fig. 5).Normal donors OA patients
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Fig. 4. Chondrocyte viability following exposure to ROS or RNS.
Conﬂuent cell cultures were exposed to increasing concentrations
of XO or peroxynitrite for 30 min and left for recovery for 24 h. After
24 h, cells were trypsinized away from the culture vessel, incubated
with trypan blue and viewed by light microscopy to calculate the
numbers of viable and dead cells. The results were obtained from
a minimum of six independent experiments, and the values repre-
sent the mean percentage of viable cells S.E.M. * indicates a signif-
icant difference (P< 0.05) in OA chondrocytes compared to those
from normal donors. Note the diminished OA chondrocyte viability
following exposure to both genotoxins.
OA patients compared to normal donors. Note the increased in ap-
optosis in OA chondrocytes following exposure to both genotoxins.Discussion
The novel ﬁndings of this study are (1) mtDNA damage
accumulates in OA chondrocytes, indicating the presence
of oxidative stress in chondrocyte mitochondria during dis-
ease progression; and (2) OA chondrocytes have lower
mtDNA repair capacity, which correlated with a decrease
in viability and a resultant increase in the induction of apo-
ptosis following experimentally induced oxidative stress.
This indicates that these cells are less able to resist or re-
cover from free radical-induced damage. Our study further
proves that oxidative stress is a contributor to the chondro-
cyte dysfunction observed in OA. The present study may
raise some concerns about the concentrations of genotox-
ins used to study differences in mtDNA repair capacity. Un-
fortunately, there is no way to correlate the amounts of
ROS/RNS generated by peroxynitrite or XO used in our
study with those present physiologically in OA cartilage, es-
pecially in the microenvironment around cartilage cells.
Free radicals are reactive species with very short half-lives,
usually measured in seconds. Therefore, ROS and RNS
levels cannot be directly and accurately measured in carti-
lage samples in order to determine the extent to which
they are elevated in aging or OA cartilage. However, by us-
ing indirect measures of ROS/RNS formation, such as mea-
surements of oxidative damage to DNA and proteins and
modulation of antioxidant capacity of cells, it has been
shown that oxidative stress and increased NO production
are present in OA cartilage22e25. The levels of ROS/RNS
112 V. I. Grishko et al.: Mitochondrial DNA in OA chondrocytesgenerators used in the present study are comparable to
those which we have used to study oxidative stress in other
cells and those used by other investigators26e28. Further-
more, the levels used were not excessively high, as the
majority of cartilage cells were able to repair the damage
they caused in mtDNA. However, the repair was more
proﬁcient in normal cells.
The present ﬁndings indicate that mtDNA integrity and
mtDNA repair are negatively affected during the progres-
sion of OA and point to the mitochondrial genome as a po-
tential therapeutic target for amelioration of OA. Also, it
needs to be emphasized that the maintenance of DNA
integrity is a complex process, which includes not only suf-
ﬁcient DNA repair enzymes, but also many antioxidant
defense systems. The analysis of the antioxidant capacity
of OA chondrocytes was beyond the scope of the current
investigation. However, this important issue will be actively
pursued in future studies.
In mammalian cells, the maintenance of mtDNA requires
an efﬁcient DNA repair system to protect them from endog-
enous and exogenous oxidative stress. ROS or RNA result-
ing from exposure to cytokines or mechanical stimuli has
been implicated as major factors in the regulation of chon-
drocyte metabolism during both normal conditions and the
development of OA. These highly reactive molecules are
known to regulate gene expression, transcription factor
activation, cellular proliferation, and cause DNA damage
and apoptosis. Because intracellular ROS are primarily
generated by the mitochondrial electron transport chain,
this mitochondrial network is a prime target for oxidative
damage and an important player in aging and many degen-
erative processes. ROS production induces damage to
lipids, proteins, and nucleic acids in mitochondria. Further-
more, ROS-induced mtDNA damage leads to mtDNA muta-
tions which in turn can lead to the synthesis of functionally
impaired respiratory chain subunits, causing respiratory
chain dysfunction and augmented ROS production21. This
vicious cycle is proposed to cause an exponential increase
in mtDNA mutations and damage over time, resulting in
enhanced aging and degenerative diseases22. We, and
others, have demonstrated that mtDNA is more sensi-
tive than nuclear DNA to damage induced by ROS or
RNS23e25. This is due to its close proximity to the inner mi-
tochondrial membrane, where ROS are endogenously gen-
erated by the electron transport chain, and the high lipid
content of the mitochondrial membrane that is potentially
susceptible to lipid peroxidation chain reactions leading to
the formation of toxic hydroperoxides and aldehydes.
ROS and chronic inﬂammation have been shown to pro-
mote chronic oxidative stress in chondrocytes, which
appears to have a signiﬁcant functional impact in experi-
mental OA26e29. Although detailed information about mito-
chondria in human chondrocytes is scanty, there are
a number of investigations supporting the notion that mito-
chondria may be involved in degeneration of cartilage and
the development of OA. In one study, a 4977-bp deletion
of mtDNA (also called the ‘‘common deletion’’) clearly asso-
ciated with degenerative abnormalities in knee cartilage
retrieved from elderly patients with idiopathic OA30. The fre-
quency of occurrence of this deletion in the OA group was
signiﬁcantly higher than in the aged cartilage group. This
deletion was found in only one specimen from subjects in
a young control group. This ﬁnding indicates that the fre-
quency of mtDNA mutations increases as cartilage ages
and is further enhanced in OA. The results of our work sup-
port this notion and show that the accumulation of mtDNA
mutations in chondrocytes during the progression of OAmay be the result of an inability to appropriately repair oxi-
dative damage in mtDNA.
A number of studies from our research group have shown
that targeting DNA repair enzymes into mitochondria can
not only enhance the repair of mtDNA lesions, but also in-
crease the viability of the treated cells and protect them
against the induction of apoptosis30e33. We believe that
mtDNA damage is involved in pathological changes in
chondrocytes during the progression of OA and directly par-
ticipates in the development of chondrocyte dysfunction and
induction of apoptosis. Future studies in animal models, will
involve the gene transfer of DNA repair enzymes into chon-
drocytes to protect against persistent mtDNA damage and
enhance mtDNA repair. These studies should establish
deﬁnitively the importance of mtDNA damage, as an early
prerequisite step, for initiating the chondrocyte dysfunction
and death seen in OA and suggest novel strategies for
aborting this deleterious process.Conﬂict of interest
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